tiprankstipranks
Trending News
More News >
BioNTech SE (DE:22UA)
XETRA:22UA
Advertisement

BioNTech SE (22UA) Similar Stocks

Compare
52 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
BioNTech SE
€91.20
$21.90B
-15.16%
12 Buy
4 Hold
0 Sell
Strong Buy
Alnylam Pharma
$456.95
$60.24B
64.00%
22 Buy
5 Hold
0 Sell
Strong Buy
Argenx Se
$804.90
$48.66B
37.53
54.63%
21 Buy
2 Hold
0 Sell
Strong Buy
Genmab
$31.85
$20.02B
15.77
34.67%
5 Buy
1 Hold
1 Sell
Moderate Buy
Moderna
$27.53
$10.68B
-51.56%
2 Buy
13 Hold
3 Sell
Hold
Springworks Therapeutics
54.83%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:22UA
BioNTech SE
91.20
-18.20
-16.64%
ALNY
Alnylam Pharma
456.95
172.63
60.72%
ARGX
Argenx Se
804.90
268.20
49.97%
GMAB
Genmab
31.85
8.32
35.36%
MRNA
Moderna
27.53
-30.76
-52.77%
SWTX
Springworks Therapeutics
46.99
16.32
53.21%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis